Mikkel Dons Müller

Mikkel Dons Müller

Guest researcher, Guest Researcher

Member of:


    Publication year:
    All
    1 - 3 out of 3Page size: 10
    1. 2023
    2. Published

      Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in Mice

      Boilesen, D. R., Neckermann, P., Willert, T., Müller, Mikkel Dons, Schrödel, S., Pertl, C., Thirion, C., Asbach, B., Wagner, R. & Holst, Peter Johannes, 2023, In: Cancer Immunology Research. 11, 2, p. 261-275 15 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors’ PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen

      Daradoumis, J., Müller, Mikkel Dons, Neckermann, P., Asbach, B., Schrödel, S., Thirion, C., Wagner, R., thor Straten, P., Holst, Peter Johannes & Boilesen, D., 2023, In: Cancers. 15, 24, p. 1-20 5863.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. 2022
    5. Published

      A systematic review of expression and immunogenicity of human endogenous retroviral proteins in cancer and discussion of therapeutic approaches

      Müller, Mikkel Dons, Holst, Peter Johannes & Nielsen, K. N., 2022, In: International Journal of Molecular Sciences . 23, 3, p. 1330

      Research output: Contribution to journal › Review › Research › peer-review

    ID: 165118304